| Authors: |
Auner HW; The Hugh and Josseline Langmuir Centre for Myeloma Research, Imperial College London, London, UK., Gavriatopoulou M; Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Delimpasi S; General Hospital Evangelismos, Athens, Greece., Simonova M; Institute of Blood Pathology & Transfusion Medicine of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine., Spicka I; Charles University and General Hospital, Prague, Czech Republic., Pour L; University Hospital Brno, Brno, Czech Republic., Dimopoulos MA; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Kriachok I; National Cancer Institute Ukraine, Kiev, Ukraine., Pylypenko H; Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine., Leleu X; Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France., Doronin V; City Clinical Hospital #40, Moscow, Russian Federation., Usenko G; City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine., Hajek R; Department of Hemato-oncology, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic., Benjamin R; Kings College Hospital NHS Foundation Trust, London, UK., Dolai TK; Nil Ratan Sircar Medical College and Hospital, Kolkata, India., Sinha DK; State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India., Venner CP; Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Garg M; University Hospitals of Leicester NHS Trust, Leicester, UK., Stevens DA; Norton Cancer Institute, Louisville, Kentucky, USA., Quach H; University of Melbourne, St. Vincent's Hospital, Melbourne, Victoria, Australia., Jagannath S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Moreau P; University Hospital, Hotel-Dieu, Nantes, France., Levy M; Baylor University Medical Center, Dallas, Texas, USA., Badros A; University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA., Anderson LD Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA., Bahlis NJ; University of Calgary, Charbonneau Cancer Research Institute, Calgary, Alberta, Canada., Facon T; CHU Lille Service des Maladies du Sang F-59000, Lille, France., Mateos MV; Hospital Universitario de Salamanca, Salamanca, Spain., Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy., Chai Y; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Arazy M; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Shah J; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Shacham S; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Kauffman MG; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Richardson PG; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Grosicki S; Medical University of Silesia, Katowice, Poland. |
